TP53 and adrenal cortex carcinoma: Previous comprehensive genome sequencing studies have explored driver mutations in ACC clinical samples and identified abnormalities in the p53/Rb and the Wnt/β-catenin signaling pathways, suggesting that these pathways are critical for ACC pathogenesis (7, 41).